The Effect of Endurance Training on Body Composition and Insulin Sensitivity in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

This study has been completed.
Sponsor:
Collaborator:
Herlev Hospital
Information provided by (Responsible Party):
Inge Holm, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT01676480
First received: January 10, 2012
Last updated: September 3, 2012
Last verified: September 2012

January 10, 2012
September 3, 2012
September 2009
September 2011   (final data collection date for primary outcome measure)
Changes in body composition and insulin sensitivity in response to training [ Time Frame: Body composition and insulin sensitivity are measured at baseline and after 12 weeks of endurance training ] [ Designated as safety issue: No ]
Changes in body composition and insulin sensitivity in response to training [ Time Frame: Pre and post 12 weeks of endurance training ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT01676480 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Effect of Endurance Training on Body Composition and Insulin Sensitivity in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
The Effect of Endurance Training on Body Composition and Insulin Sensitivity in Prostate Cancer Patients Receiving ADT

The purpose of the present study is to investigate if endurance training can be used as a therapeutic action against the adverse metabolic disturbances and unfavourable changes in body composition that accompany the androgen deprivation therapy (ADT) treatment in prostate cancer patients.

Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Prostate Cancer
Behavioral: Endurance training
12 weeks of endurance training 3 times per week
  • Experimental: ADT group
    Intervention: Behavioral: Endurance training
  • Experimental: Control group
    Intervention: Behavioral: Endurance training
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
20
September 2011
September 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Prostate cancer patients receiving ADT for at least 3 months
  • Healthy age and BMI matched controls

Exclusion Criteria:

  • severe cardiovascular disease
  • severe arthritis
  • severe neuropathy
  • severe hypertension
  • therapy with antidiabetic agents
  • VO2max > 30.
Male
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
Denmark
 
NCT01676480
H-4-2009-102
Yes
Inge Holm, Rigshospitalet, Denmark
Inge Holm
Herlev Hospital
Study Director: Bente K Pedersen Centre of Inflammation and Metabolism, Rigshospitalet
Rigshospitalet, Denmark
September 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP